Albert J. Robichaud

2018

In 2018, Albert J. Robichaud earned a total compensation of $3.7M as Chief Scientific Officer at Sage Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$181,625
Option Awards$3,062,756
Salary$412,783
Other$10,098
Total$3,667,262

Robichaud received $3.1M in option awards, accounting for 84% of the total pay in 2018.

Robichaud also received $181.6K in non-equity incentive plan, $412.8K in salary and $10.1K in other compensation.

Rankings

In 2018, Albert J. Robichaud's compensation ranked 3,076th out of 14,244 executives tracked by ExecPay. In other words, Robichaud earned more than 78.4% of executives.

ClassificationRankingPercentile
All
3,076
out of 14,244
78th
Division
Manufacturing
1,140
out of 5,758
80th
Major group
Chemicals And Allied Products
394
out of 2,119
81st
Industry group
Drugs
324
out of 1,808
82nd
Industry
Pharmaceutical Preparations
247
out of 1,382
82nd

Pay ratio

Albert J. Robichaud's Pay$3,667,262
Median Employee's Pay$589,166
Pay Ratio

to 1

In 2018, the annual total compensation of Albert J. Robichaud was $3,667,262.

The annual total compensation of the median employee at Sage Therapeutics was $589,166.

The ratio of Albert J. Robichaud's pay to the pay of median employee was therefore to one.

Source: SEC filing on April 29, 2021.

Robichaud's colleagues

We found five more compensation records of executives who worked with Albert J. Robichaud at Sage Therapeutics in 2018.

2018

Jeffrey Jonas

Sage Therapeutics

Chief Executive Officer

2018

Michael Cloonan

Sage Therapeutics

Chief Business Officer

2018

Anne Cook

Sage Therapeutics

General Counsel

2018

Kimi Iguchi

Sage Therapeutics

Chief Financial Officer

2018

Stephen Kanes

Sage Therapeutics

Chief Medical Officer

News

In-depth

You may also like